(Q33879944)

29 July 2017

1 reference

title

Chronic graft-versus-host disease: is there an alternative to the conventional treatment? (English)

1 reference

29 July 2017

Gaziev D

1

1 reference

29 July 2017

Galimberti M

series ordinal

2

1 reference

29 July 2017

Lucarelli G

series ordinal

3

1 reference

29 July 2017

Polchi P

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

Bone Marrow Transplantation

29 July 2017

published in

1 reference

29 July 2017

volume

25

1 reference

29 July 2017

issue

7

1 reference

29 July 2017

page(s)

689-696

1 reference

Bone marrow transplantation in patients with thalassemia

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

New and experimental therapies for treating graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Acute and chronic graft-versus-host disease in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Tacrolimus, a new immunosuppressant--a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Clinical pharmacokinetics of clofazimine. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Clofazimine in the treatment of discoid lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Nedocromil sodium ameliorates skin manifestations in a murine model of chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Infection in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Reimmunization after blood or marrow stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Long-term cyclosporin therapy may decrease the risk of chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Thalidomide treatment for chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

PUVA therapy for chronic cutaneous graft-vs-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

PUVA and cancer: a large-scale epidemiological study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Development of multiple cutaneous squamous cell carcinomas during PUVA treatment for chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Phototherapy in the treatment of cutaneous graft-versus-host disease. Our preliminary experience in resistant patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Successful treatment of heart transplant rejection with photopheresis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Low-dose (one gray) total-lymphoid irradiation for extensive, drug-resistant chronic graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Successful treatment of chronic cutaneous graft-versus-host-disease (GVHD) with penicillamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: effect of halofuginone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

"Suicide" gene for the control of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702235

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1702235

1 reference

Dimensions Publication ID

29 July 2017

1034114882

0 references

1 reference